Search Results 1211-1220 of 15462 for alt

  1. Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer - Mayo Clinic

    Aspartate aminotransferase (AST) serum glutamic-oxaloacetic transaminase (SGOT)/alanine aminotransferase (ALT) serum glutamate pyruvate transaminase (SGPT) ...

  2. Safety Study of SEA-CD40 in Cancer Patients - Mayo Clinic

    Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤2.5 x ULN (≤5 x ULN if there is evidence of hepatic involvement by malignant disease).

  3. Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer - Mayo Clinic

    ... [ALT]) =< 3.0 x institutional upper limit of normal; Creatinine =< 1.5 x ULN; Serum albumin >= 2.8 g/dL; Lipase < 2.0 x ULN and no radiologic or clinical ...

  4. A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis - Mayo Clinic

    AST, ALT >1.5 x ULN; Bilirubin >1.5 x ULN; Creatinine clearance <30 mL/min; Airway obstruction (pre-bronchodilator FEV1/FVC <0.7); Other clinically significant ...

  5. Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA) - Mayo Clinic

    AST (SGOT), ALT (SGPT) or BUN >2 x ULN (upper limit of normal) or creatinine >1.5 mg/dL or any other laboratory abnormality considered by the examining ...

  6. Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

    Aspartate transaminase (AST) and alanine aminotransferase (ALT) =< 2.5 x ULN OR =< 5 x ULN for subjects with liver metastases; Albumin > 2.5 mg/dL (25 g/L) ...

  7. A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

    SGPT (ALT) ≤ 2.5X the institutional ULN;; SGOT (AST) ≤ 2.5X the institutional ULN;; Alkaline Phosphatase ≤ 1.5X the institutional ULN. Participants in the ...

  8. A Phase 1/2 Study To Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Efficacy Of HMB-001 In Glanzmann Thrombasthenia - Mayo Clinic

    3a kidney disease), measured by an eGFR of ≥ 45 ml/min/1.73m2 at Screening. 2. An AST, ALT, and total bilirubin ≤1.5 ULN range at Screening. For ...

  9. A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma - Mayo Clinic

    Aspartate Aminotransferase (AST) and Alanine transaminase (ALT) < 5.0x the upper limit of normal (ULN); Glomerular filtration rate (GFR) > 45 mL/min/1.73m^2 ...

  10. Dual BET And CBP/p300 Inhibitor In Patients With Targeted Advanced Solid Tumors And Hematological Malignancies - Mayo Clinic

    Adequate liver function: total bilirubin ≤ 1.5 x ULN; alanine aminotransferase (ALT) or aspartate Aminotransferase (AST) ≤ 2.5 x ULN or ≤ 5 x ULN in patients ...